Mycophenolate Mofetil Versus Azathioprine in Organ Transplantation

Paolo Cravedi; Annalisa Perna; Piero Ruggenenti; Giuseppe Remuzzi

doi:10.1111/j.1600-6143.2009.02853.x

Related publications

Letter2006

Is Mycophenolate Mofetil Better Than Azathioprine in Organ Transplantation?

Piero Ruggenenti, Giuseppe Remuzzi

Article2007

Mycophenolate Mofetil versus Azathioprine for Prevention of Chronic Allograft Dysfunction in Renal Transplantation

Giuseppe Remuzzi, Paolo Cravedi, Marco Costantini, Mariadomenica Lesti, María Ganeva, Giulia Gherardi, Bogdan Ene‐Iordache, Eliana Gotti, Donato Donati, Maurizio Salvadori, Silvio Sandrini, Giuseppe Segoloni, Stefano Federico, Paolo Rigotti, Vito Sparacino, Piero Ruggenenti

Article2004

Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial

Giuseppe Remuzzi, Mariadomenica Lesti, Eliana Gotti, María Ganeva, Borislav D. Dimitrov, Bogdan Ene‐Iordache, Giulia Gherardi, Donato Donati, Maurizio Salvadori, Silvio Sandrini, Umberto Valente, Giuseppe Segoloni, Georges Mourad, Stefano Federico, Paolo Rigotti, Vito Sparacino, Jean‐Louis Bosmans, Norberto Perico, Piero Ruggenenti

Article2002

Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation

Dario Cattaneo, Norberto Perico, Flavio Gaspari, Eliana Gotti, Giuseppe Remuzzi

Article2021

Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial

Piero Ruggenenti, Paolo Cravedi, Eliana Gotti, Annarita Plati, Maddalena Marasà, Silvio Sandrini, Nicola Bossini, Franco Citterio, Enrico Minetti, Domenico Montanaro, Ettore Sabadini, Regina Tardanico, Davide Martinetti, Flavio Gaspari, Alessandro Villa, Annalisa Perna, Francesco Peraro, Giuseppe Remuzzi